Beta-sitosterol ameliorates the IKKβ/NF-κB and c-Jun-N-terminal kinase signaling pathways in the adipose tissue by downregulating inflammatory events, thereby inhibiting obesity-induced insulin resistance [24]. The gene discussed is NFKB1; the disease is obesity due to melanocortin 4 receptor deficiency.